Gottfried Reznicek

University of Vienna — Austria

Biochemistry, Genetics and Molecular Biology · Life Sciences

25h-index2.1kcitations109works0.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Natural product bioactivities and synthesis(30), Phytochemistry and Biological Activities(26), Essential Oils and Antimicrobial Activity(13), Antibiotics Pharmacokinetics and Efficacy(13), Dialysis and Renal Disease Management(9)

Publications109 total

Biosynthetic Potential of the Endophytic Fungus Helotiales sp. BL73 Revealed via Compound Identification and Genome Mining
Applied and Environmental Microbiology·2022· 15 citedOpen Access
Triamcinolone acetonide can be detected in cerebrospinal fluid after intratympanic injection
European Journal of Pharmaceutics and Biopharmaceutics·2021· 2 cited
Evaluation of Levels of Triamcinolone Acetonide in Human Perilymph and Plasma After Intratympanic Application in Patients Receiving Cochlear Implants
JAMA Otolaryngology–Head & Neck Surgery·2021· 9 citedOpen Access
Azithromycin concentrations during long-term regimen, a pilot study in patients with MALT lymphoma.
PubMed·2021· 6 citedOpen Access
Azithromycin Concentrations During Long-Term Regimen in Patients With MALT Lymphoma
Research Square (Research Square)·2021Open Access
Short Chain (≤C4) Esterification Increases Bioavailability of Rosmarinic Acid and Its Potency to Inhibit Vascular Smooth Muscle Cell Proliferation
Frontiers in Pharmacology·2021· 20 citedOpen Access
Intratympanic application of poloxamer 407 hydrogels results in sustained N-acetylcysteine delivery to the inner ear
European Journal of Pharmaceutics and Biopharmaceutics·2020· 38 cited
Compatibility of aztreonam in four commercial peritoneal dialysis fluids
Scientific Reports·2020· 3 citedOpen Access
Compatibility of ciprofloxacin with commercial peritoneal dialysis solutions
Scientific Reports·2019· 14 citedOpen Access
Compatibility of linezolid with commercial peritoneal dialysis solutions
American Journal of Health-System Pharmacy·2018· 3 cited
Influence of different peritoneal dialysis fluids on the in vitro activity of fosfomycin against Escherichia coli, Staphylococcus aureus, Staphylococcus epidermidis, and Pseudomonas aeruginosa
European Journal of Clinical Microbiology & Infectious Diseases·2018· 8 citedOpen Access
Quality Control of Valerianae Radix by Attenuated Total Reflection Fourier Transform Infrared (ATR-FTIR) Spectroscopy
Planta Medica·2017· 7 cited
Compatibility of fosfomycin with different commercial peritoneal dialysis solutions
European Journal of Clinical Microbiology & Infectious Diseases·2017· 12 citedOpen Access
Addendum: Šarić-Kundalić, B.; Fialová, S.; Dobeš, C.; Ölzant, S.; Tekeľová, D.; Grančai, D.; Reznicek, G.; Saukel, J. Multivariate Numerical Taxonomy of Mentha Species, Hybrids, Varieties and Cultivars. Sci. Pharm. 2009, 77, 851–876
Scientia Pharmaceutica·2016· 3 citedOpen Access
Influence of Different Peritoneal Dialysis Fluids on the <i>In Vitro</i> Activity of Cefepime, Ciprofloxacin, Ertapenem, Meropenem and Tobramycin against <i>Escherichia Coli</i>
Peritoneal Dialysis International·2016· 11 citedOpen Access
Compatibility of Meropenem with Different Commercial Peritoneal Dialysis Solutions
Peritoneal Dialysis International·2016· 7 cited
An Open, Randomized, Single-Center, Crossover Pharmacokinetic Study of Meropenem after Intraperitoneal and Intravenous Administration in Patients Receiving Automated Peritoneal Dialysis
Antimicrobial Agents and Chemotherapy·2016· 15 citedOpen Access
Pharmacokinetic profile of meropenem after intraperitoneal and intravenous
2016
Simultaneous determination of active component and vehicle penetration from F-DPPC liposomes into porcine skin layers
European Journal of Pharmaceutics and Biopharmaceutics·2015· 11 cited
The influence of different peritoneal dialysis fluids on the in vitro activity of ampicillin, daptomycin, and linezolid against Enterococcus faecalis
European Journal of Clinical Microbiology & Infectious Diseases·2015· 22 cited
page 1 of 6Next →

Frequent Co-authors

J. Jurenitsch(10), Verena M. Dirsch(7), Martin Zehl(7), Walter Jäger(7), Elke H. Heiß(6), Ernst Haslinger(6), Heinz Burgmann(6), Markus Zeitlinger(6), Brigitte Kopp(5), Wolfgang Poeppl(5), Sylvia Vogl(4), Paolo Picker(4), Nanang Fakhrudin(4), Atanas G. Atanasov(4), Christoph Wawrosch(4), Johannes Saukel(4), Alexandra Maier‐Salamon(4), Claudia Valenta(4), Ernst Urban(4), Sabine Glasl(4)